Intranasal Benzodiazepine compositions
First Claim
Patent Images
1. A pharmaceutical composition for intranasal administration comprising:
- an effective amount of a benzodiazepine or pharmaceutically acceptable salt thereof;
a nasal carrier; and
at least one or more sweeteners, flavoring agents, or masking agents or combinations thereof.
2 Assignments
0 Petitions
Accused Products
Abstract
A pharmaceutical composition for intranasal administration to a mammal. The pharmaceutical composition comprises an effective amount of a benzodiazepine or pharmaceutically acceptable salt thereof; and a nasal carrier. In some embodiments, the pharmaceutical composition when administered intranasally produces a rapid physiological response. Pharmaceutical compositions may also include at least one or more sweeteners, flavoring agents, or masking agents or combinations thereof.
-
Citations
26 Claims
-
1. A pharmaceutical composition for intranasal administration comprising:
- an effective amount of a benzodiazepine or pharmaceutically acceptable salt thereof;
a nasal carrier; and
at least one or more sweeteners, flavoring agents, or masking agents or combinations thereof. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10)
- an effective amount of a benzodiazepine or pharmaceutically acceptable salt thereof;
-
11. A pharmaceutical composition for intranasal administration to a mammal comprising:
- an effective amount of midazolam or pharmaceutically acceptable salt thereof, polyethylene glycol, saccharin powder, and propylene glycol.
- View Dependent Claims (12, 13, 14, 15, 16, 17, 18, 19)
-
20. A method of treating a mammal in need of rapid sedation, anxiolysis, amnesia, or induction of anesthesia comprising intranasally administering to the mammal an effective amount of a pharmaceutical composition comprising midazolam or pharmaceutically acceptable salt thereof;
- and a nasal carrier;
wherein the rapid sedation, anxiolysis, amnesia, or induction of anesthesia occurs within 5 minutes after intranasal administration.
- and a nasal carrier;
-
21. A method of treating a mammal in need of rapid sedation, anxiolysis, amnesia, or induction of anesthesia comprising intranasally administering to the mammal an effective amount of a pharmaceutical composition comprising midazolam or pharmaceutically acceptable salt thereof;
- a nasal carrier; and
at least one or more sweeteners, flavoring agents, or masking agents or combinations thereof. - View Dependent Claims (22, 23, 24, 25)
- a nasal carrier; and
-
26. A method of making a pharmaceutical composition for intranasal administration comprising adding at least one or more sweeteners, flavoring agents, or masking agents or combinations thereof to a pharmaceutical composition comprising midazolam or pharmaceutically acceptable salt thereof, and a nasal carrier so as to make the pharmaceutical composition.
Specification